Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes

dc.contributor.authorFernández Barat, Laia
dc.contributor.authorBen-Aicha, Soumaya
dc.contributor.authorMotos, Ana
dc.contributor.authorVila Estapé, Jordi
dc.contributor.authorMarco Reverté, Francesc
dc.contributor.authorRigol Muxart, Montserrat
dc.contributor.authorMuñoz López, Laura
dc.contributor.authorBassi, Gianluigi Li
dc.contributor.authorFerrer Monreal, Miquel
dc.contributor.authorTorres Martí, Antoni
dc.date.accessioned2018-11-14T19:34:01Z
dc.date.available2018-11-14T19:34:01Z
dc.date.issued2018-08-09
dc.date.updated2018-11-14T19:34:01Z
dc.description.abstractOur aim was to demonstrate that biofilm formation in a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) can be enhanced by environment exposure in an endotracheal tube (ETT) and to determine how it is affected by systemic treatment and atmospheric conditions. Second, we aimed to assess biofilm production dynamics after extubation. We prospectively analyzed 70 ETT samples obtained from pigs randomized to be untreated (controls, n = 20), or treated with vancomycin (n = 32) or linezolid (n = 18). A clinical MRSA strain (MRSA-in) was inoculated in pigs to create a pneumonia model, before treating with antibiotics. Tracheally intubated pigs with MRSA severe pneumonia, were mechanically ventilated for 69 ± 16 hours. All MRSA isolates retrieved from ETTs (ETT-MRSA) were tested for their in vitro biofilm production by microtiter plate assay. In vitro biofilm production of MRSA isolates was sequentially studied over the next 8 days post-extubation to assess biofilm capability dynamics over time. All experiments were performed under ambient air (O2) or ambient air supplemented with 5% CO2. We collected 52 ETT-MRSA isolates (placebo N = 19, linezolid N = 11, and vancomycin N = 22) that were clonally identical to the MRSA-in. Among the ETT-MRSA isolates, biofilm production more than doubled after extubation in 40% and 50% under 5% CO2 and O2, respectively. Systemic antibiotic treatment during intubation did not affect this outcome. Under both atmospheric conditions, biofilm production for MRSA-in was at least doubled for 9 ETT-MRSA isolates, and assessment of these showed that biofilm production decreased progressively over a 4-day period after extubation. In conclusion, a weak biofilm producer MRSA strain significantly enhances its biofilm production within an ETT, but it is influenced by the ETT environment rather than by the systemic treatment used during intubation or by the atmospheric conditions used for bacterial growth.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec681796
dc.identifier.issn2045-2322
dc.identifier.pmid30093624
dc.identifier.urihttps://hdl.handle.net/2445/126116
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41598-018-30494-7
dc.relation.ispartofScientific Reports, 2018, vol. 8, num. 11906
dc.relation.urihttps://doi.org/10.1038/s41598-018-30494-7
dc.rightscc-by (c) Fernández Barat, Laia et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Fonaments Clínics)
dc.subject.classificationStaphylococcus aureus
dc.subject.classificationResistència als medicaments
dc.subject.classificationIntubació
dc.subject.classificationDiagnòstic microbiològic
dc.subject.otherStaphylococcus aureus
dc.subject.otherDrug resistance
dc.subject.otherIntubation
dc.subject.otherDiagnostic microbiology
dc.titleAssessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
681796.pdf
Mida:
1.54 MB
Format:
Adobe Portable Document Format